المؤلفون: Long A; Taiho Oncology, Inc., Princeton, New Jersey, USA., Yamamiya I; Taiho Pharmaceutical Co., Ltd, Tsukuba, Ibaraki, Japan., Valentine M; Celerion, Lincoln, Nebraska, USA., Machnes Z; Celerion, Lincoln, Nebraska, USA., Hangai N; Taiho Oncology, Inc., Princeton, New Jersey, USA., Anderson B; Taiho Oncology, Inc., Princeton, New Jersey, USA., Wacheck V; Taiho Oncology, Inc., Princeton, New Jersey, USA., Gao L; Taiho Oncology, Inc., Princeton, New Jersey, USA.

المصدر: Clinical and translational science [Clin Transl Sci] 2024 Sep; Vol. 17 (9), pp. e70012.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

مواضيع طبية MeSH: Drug Interactions* , ATP Binding Cassette Transporter, Subfamily G, Member 2*/metabolism , Rosuvastatin Calcium*/pharmacokinetics , Rosuvastatin Calcium*/administration & dosage , Neoplasm Proteins*/antagonists & inhibitors , Neoplasm Proteins*/metabolism , Digoxin*/pharmacokinetics , Digoxin*/administration & dosage , ATP Binding Cassette Transporter, Subfamily B, Member 1*/antagonists & inhibitors , ATP Binding Cassette Transporter, Subfamily B, Member 1*/metabolism, Humans ; Adult ; Male ; Female ; Middle Aged ; Young Adult ; Adolescent ; Healthy Volunteers ; Area Under Curve ; ATP Binding Cassette Transporter, Subfamily B/antagonists & inhibitors ; ATP Binding Cassette Transporter, Subfamily B/metabolism

المؤلفون: Ji N; Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Tianjin Medical University, Tianjin 300070, China., Li H; Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Tianjin Medical University, Tianjin 300070, China; Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Tianjin Medical University, Tianjin 300070, China., Zhang Y; Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Tianjin Medical University, Tianjin 300070, China; Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Tianjin Medical University, Tianjin 300070, China., Li Y; Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Tianjin Medical University, Tianjin 300070, China; Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Tianjin Medical University, Tianjin 300070, China., Wang P; Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Tianjin Medical University, Tianjin 300070, China; Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Tianjin Medical University, Tianjin 300070, China., Chen X; Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Tianjin Medical University, Tianjin 300070, China; Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Tianjin Medical University, Tianjin 300070, China., Liu YN; Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Tianjin Medical University, Tianjin 300070, China; Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Tianjin Medical University, Tianjin 300070, China., Wang JQ; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA., Yang Y; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA., Chen ZS; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA., Li Y; Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Tianjin Medical University, Tianjin 300070, China. Electronic address: yli08@tmu.edu.cn., Wang R; Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Tianjin Medical University, Tianjin 300070, China; Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Tianjin Medical University, Tianjin 300070, China. Electronic address: wangran@tmu.edu.cn., Kong D; Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin 300060, China; Tianjin Medical University, Tianjin 300070, China; Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Tianjin Medical University, Tianjin 300070, China. Electronic address: kongdexin@tmu.edu.cn.

المصدر: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy [Drug Resist Updat] 2024 Sep; Vol. 76, pp. 101100. Date of Electronic Publication: 2024 Jun 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 9815369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2084 (Electronic) Linking ISSN: 13687646 NLM ISO Abbreviation: Drug Resist Updat Subsets: MEDLINE

مواضيع طبية MeSH: ATP Binding Cassette Transporter, Subfamily B*/metabolism , ATP Binding Cassette Transporter, Subfamily B*/genetics , Drug Resistance, Multiple*/drug effects , Drug Resistance, Neoplasm*/drug effects , Lansoprazole*/pharmacology , Lysosomes*/metabolism , Lysosomes*/drug effects , Proton Pump Inhibitors*/pharmacology, Animals ; Humans ; Mice ; Antineoplastic Agents/pharmacology ; ATP Binding Cassette Transporter, Subfamily G, Member 2/metabolism ; ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics ; Cell Line, Tumor ; Mice, Nude ; Molecular Docking Simulation ; Neoplasm Proteins ; Neoplasms/drug therapy ; Neoplasms/metabolism ; Neoplasms/pathology ; Xenograft Model Antitumor Assays

المؤلفون: Lentzas A; Division of Pharmacology, The Netherlands Cancer Institute, Room H3.010, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., de Gooijer MC; Division of Pharmacology, The Netherlands Cancer Institute, Room H3.010, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M1 3WE, UK.; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK., Zuidema S; Division of Pharmacology, The Netherlands Cancer Institute, Room H3.010, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Meurs A; Division of Pharmacology, The Netherlands Cancer Institute, Room H3.010, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Çitirikkaya CH; Division of Pharmacology, The Netherlands Cancer Institute, Room H3.010, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Venekamp N; Division of Pharmacology, The Netherlands Cancer Institute, Room H3.010, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.; Department of Pharmacy, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, Utrecht, 3584 CG, The Netherlands., van Tellingen O; Division of Pharmacology, The Netherlands Cancer Institute, Room H3.010, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. o.v.tellingen@nki.nl.; Mouse Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands. o.v.tellingen@nki.nl.

المصدر: Fluids and barriers of the CNS [Fluids Barriers CNS] 2024 Aug 05; Vol. 21 (1), pp. 62. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Biomed Central Country of Publication: England NLM ID: 101553157 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-8118 (Electronic) Linking ISSN: 20458118 NLM ISO Abbreviation: Fluids Barriers CNS Subsets: MEDLINE

مواضيع طبية MeSH: Mice, Knockout* , Tetrahydroisoquinolines*/pharmacology , Tetrahydroisoquinolines*/administration & dosage , ATP Binding Cassette Transporter, Subfamily G, Member 2*/metabolism , ATP Binding Cassette Transporter, Subfamily G, Member 2*/antagonists & inhibitors , Brain*/metabolism , Brain*/drug effects , Acridines*/pharmacology , Acridines*/administration & dosage , Blood-Brain Barrier*/metabolism , Blood-Brain Barrier*/drug effects, Animals ; Mice ; Quinolines/pharmacology ; Quinolines/pharmacokinetics ; Quinolines/administration & dosage ; Drug Delivery Systems/methods ; ATP Binding Cassette Transporter, Subfamily B/metabolism ; ATP Binding Cassette Transporter, Subfamily B/antagonists & inhibitors ; ATP Binding Cassette Transporter, Subfamily B/genetics ; Male ; Mice, Inbred C57BL

المؤلفون: Volpe DA; Division of Applied Regulatory Science, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, Maryland, 20993-0002, USA. donna.volpe@fda.hhs.gov.

المصدر: The AAPS journal [AAPS J] 2024 Jul 10; Vol. 26 (4), pp. 79. Date of Electronic Publication: 2024 Jul 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

مواضيع طبية MeSH: ATP Binding Cassette Transporter, Subfamily G, Member 2*/metabolism , ATP Binding Cassette Transporter, Subfamily G, Member 2*/genetics , Neoplasm Proteins*/metabolism , Neoplasm Proteins*/genetics, Humans ; Multidrug Resistance-Associated Protein 2 ; ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism ; ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics ; Gene Knockout Techniques ; Biological Transport ; Multidrug Resistance-Associated Proteins/metabolism ; Multidrug Resistance-Associated Proteins/genetics ; Cell Line ; Digoxin/pharmacology ; Digoxin/pharmacokinetics ; Digoxin/metabolism ; Prazosin/pharmacology ; Paclitaxel/pharmacology ; Animals

المؤلفون: Jiménez-Cortegana C; Department of Medical Biochemistry, Molecular Biology and Immunology, University of Seville Medical School, 41009 Seville, Spain., López-Enríquez S; Department of Medical Biochemistry, Molecular Biology and Immunology, University of Seville Medical School, 41009 Seville, Spain., Alba G; Department of Medical Biochemistry, Molecular Biology and Immunology, University of Seville Medical School, 41009 Seville, Spain., Santa-María C; Department of Biochemistry and Molecular Biology, University of Seville Pharmacy School, 41012 Seville, Spain., Martín-Núñez GM; Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., Moreno-Ruiz FJ; Unidad de Gestión Clínica de Cirugía General, Digestiva y Trasplantes, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., Valdés S; Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, 29010 Málaga, Spain., García-Serrano S; Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, 29010 Málaga, Spain., Rodríguez-Díaz C; Unidad de Gestión Clínica de Aparato Digestivo, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., Ho-Plágaro A; Unidad de Gestión Clínica de Aparato Digestivo, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., Fontalba-Romero MI; Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain., García-Fuentes E; Unidad de Gestión Clínica de Aparato Digestivo, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; CIBER Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 29010 Málaga, Spain.; Departamento de Farmacología, Facultad de Medicina, Universidad de Málaga, 29010 Málaga, Spain., Garrido-Sánchez L; Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 29010 Málaga, Spain., Sánchez-Margalet V; Department of Medical Biochemistry, Molecular Biology and Immunology, University of Seville Medical School, 41009 Seville, Spain.; Institute of Biomedicine of Seville (IBiS), Hospital Universitario Virgen del Rocío/Virgen Macarena, CSIC, Universidad de Sevilla, 41013 Seville, Spain.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 09; Vol. 25 (14). Date of Electronic Publication: 2024 Jul 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Obesity, Morbid*/metabolism , Obesity, Morbid*/surgery , Obesity, Morbid*/genetics , Leukocytes, Mononuclear*/metabolism , Receptors, Leptin*/genetics , Receptors, Leptin*/metabolism , Cholesterol*/metabolism , Liver X Receptors*/metabolism , Liver X Receptors*/genetics , ATP Binding Cassette Transporter 1*/genetics , ATP Binding Cassette Transporter 1*/metabolism , Liver*/metabolism, Humans ; Male ; Female ; Adult ; Middle Aged ; ATP Binding Cassette Transporter, Subfamily G, Member 1/metabolism ; ATP Binding Cassette Transporter, Subfamily G, Member 1/genetics ; Signal Transduction ; Biological Transport ; Gene Expression Regulation ; Non-alcoholic Fatty Liver Disease/metabolism ; Non-alcoholic Fatty Liver Disease/genetics ; Adaptor Proteins, Signal Transducing/metabolism ; Adaptor Proteins, Signal Transducing/genetics

المؤلفون: Zhao Y; Department of Stomatology, Xingtai People's Hospital, Xingtai, Hebei Province, China., Xu S; Department of Clinical Laboratory, Xingtai People's Hospital, Xingtai, Hebei Province, China., Hao W; Department of Stomatology, Xingtai People's Hospital, Xingtai, Hebei Province, China., Fu Y; Department of Clinical Laboratory, Xingtai People's Hospital, Xingtai, Hebei Province, China.

المصدر: Cell biochemistry and function [Cell Biochem Funct] 2024 Jul; Vol. 42 (5), pp. e4083.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8305874 Publication Model: Print Cited Medium: Internet ISSN: 1099-0844 (Electronic) Linking ISSN: 02636484 NLM ISO Abbreviation: Cell Biochem Funct Subsets: MEDLINE

مواضيع طبية MeSH: Flavonoids*/pharmacology , Drug Resistance, Multiple*/drug effects , Drug Resistance, Neoplasm*/drug effects , Apoptosis*/drug effects , Paclitaxel*/pharmacology , ATP Binding Cassette Transporter, Subfamily B, Member 1*/metabolism , ATP Binding Cassette Transporter, Subfamily B, Member 1*/genetics, Humans ; Cell Line, Tumor ; Cell Cycle Checkpoints/drug effects ; ATP Binding Cassette Transporter, Subfamily B/metabolism ; ATP Binding Cassette Transporter, Subfamily B/genetics ; ATP Binding Cassette Transporter, Subfamily B/antagonists & inhibitors ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/chemistry ; Flavones

المؤلفون: Qin W; Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China., Zhang L; Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China., Wang X; Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China., Liu B; Department of Pain Management, China-Japan Friendship Hospital, Beijing 100029, China., Xu L; Department of Pain Management, China-Japan Friendship Hospital, Beijing 100029, China., Liu L; Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address: liulihong@zryhyy.com.cn., Fan B; Department of Pain Management, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address: fanbifa@zryhyy.com.cn.

المصدر: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Jul; Vol. 176, pp. 116897. Date of Electronic Publication: 2024 Jun 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: ATP Binding Cassette Transporter, Subfamily B*/genetics , ATP Binding Cassette Transporter, Subfamily B*/metabolism , Analgesics, Opioid*/pharmacokinetics , Analgesics, Opioid*/administration & dosage , Polymorphism, Single Nucleotide*/genetics , Oxycodone*/pharmacokinetics , Oxycodone*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Aged ; Cancer Pain/drug therapy ; Cancer Pain/genetics ; Adult ; ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics ; ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism ; Intestinal Mucosa/metabolism ; Genotype

المؤلفون: Błauż A; Cytometry Laboratory, Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, Poland. Electronic address: andrzej.blauz@biol.uni.lodz.pl., Wachulec M; Cytometry Laboratory, Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, Poland., Rychlik B; Cytometry Laboratory, Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, Poland.

المصدر: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Jul; Vol. 176, pp. 116861. Date of Electronic Publication: 2024 Jun 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: ATP Binding Cassette Transporter, Subfamily G, Member 2*/metabolism , ATP Binding Cassette Transporter, Subfamily G, Member 2*/genetics , Mitoxantrone*/pharmacology , Drug Resistance, Neoplasm*/drug effects , Neoplasm Proteins*/metabolism , Neoplasm Proteins*/genetics , Oncostatin M*/metabolism, Humans ; Cell Line, Tumor ; Drug Resistance, Multiple/drug effects ; ATP Binding Cassette Transporter, Subfamily B/metabolism ; ATP Binding Cassette Transporter, Subfamily B/genetics

المؤلفون: Meshko B; Department of Ophthalmology, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937 Cologne, Germany., Volatier TLA; Department of Ophthalmology, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937 Cologne, Germany., Mann J; Department of Ophthalmology, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937 Cologne, Germany., Kluth MA; RHEACELL GmbH & Co. KG, Im Neuenheimer Feld 517, 69120 Heidelberg, Germany., Ganss C; RHEACELL GmbH & Co. KG, Im Neuenheimer Feld 517, 69120 Heidelberg, Germany., Frank MH; Transplant Research Program, Boston Children's Hospital, Boston, MA 02115, USA.; Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.; School of Medical and Health Sciences, Edith Cowan University, Perth, WA 6027, Australia., Frank NY; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.; Department of Medicine, VA Boston Healthcare System, Boston, MA 02132, USA.; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA., Ksander BR; Massachusetts Eye & Ear Infirmary, Schepens Eye Research Institute, Boston, MA 02114, USA., Cursiefen C; Department of Ophthalmology, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50937 Cologne, Germany.; Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD) Research Center, Joseph-Stelzmann-Str. 26, 50931 Cologne, Germany., Notara M; Department of Ophthalmology, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50937 Cologne, Germany.; Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD) Research Center, Joseph-Stelzmann-Str. 26, 50931 Cologne, Germany.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 07; Vol. 25 (17). Date of Electronic Publication: 2024 Sep 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Mesenchymal Stem Cells*/metabolism , Mesenchymal Stem Cells*/cytology , Vascular Endothelial Growth Factor A*/metabolism , ATP Binding Cassette Transporter, Subfamily B*/metabolism , ATP Binding Cassette Transporter, Subfamily B*/genetics, Humans ; Cell Differentiation ; Vascular Endothelial Growth Factor C/metabolism ; Cell Proliferation ; Limbus Corneae/metabolism ; Limbus Corneae/cytology ; ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism ; Jurkat Cells ; Cells, Cultured ; Stromal Cells/metabolism ; Coculture Techniques ; Endothelial Cells/metabolism

المؤلفون: Besse A; Laboratory of Experimental Oncology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic., Sedlarikova L; Babak Myeloma Group, Department of Pathological Physiology, Masaryk University, Brno, 62500, Czech Republic.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic., Buechler L; Laboratory of Experimental Oncology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland., Kraus M; Laboratory of Experimental Oncology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland., Yang CH; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Strakova N; Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, 612 00, Czech Republic.; Veterinary Research Institute, Brno, 62500, Czech Republic., Soucek K; Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, 612 00, Czech Republic.; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic., Navratil J; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, 62500, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic., Svoboda M; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, 62500, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic., Welm AL; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Joerger M; Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland., Driessen C; Laboratory of Experimental Oncology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland.; Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland., Besse L; Laboratory of Experimental Oncology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, 9000, Switzerland. Lenka.besse@kssg.ch.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic. Lenka.besse@kssg.ch.

المصدر: British journal of cancer [Br J Cancer] 2024 Sep; Vol. 131 (5), pp. 918-930. Date of Electronic Publication: 2024 Jul 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/pathology , Oligopeptides*/pharmacology , HIV Protease Inhibitors*/pharmacology , Nelfinavir*/pharmacology , Lopinavir*/pharmacology , Drug Synergism* , Bortezomib*/pharmacology , ATP Binding Cassette Transporter, Subfamily G, Member 2*/metabolism , ATP Binding Cassette Transporter, Subfamily G, Member 2*/antagonists & inhibitors , Unfolded Protein Response*/drug effects, Humans ; Cell Line, Tumor ; Female ; Proteasome Inhibitors/pharmacology ; Neoplasm Proteins/antagonists & inhibitors ; Neoplasm Proteins/metabolism ; X-Box Binding Protein 1/metabolism ; X-Box Binding Protein 1/genetics ; ATP Binding Cassette Transporter, Subfamily B/metabolism ; Endoplasmic Reticulum Stress/drug effects ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Apoptosis/drug effects